PP33 Non-Neoplastic Thyroid Disorders - Thyroid Immunology

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Thyroid/HPT Axis-Bench to Bedside
Sunday, April 3, 2016: 11:30 AM-11:45 AM
Hall B2 (BCEC)
Chairs:
Ulla Feldt-Rasmussen, Professor, MD, DMSc, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark and Terry F Davies, MD, Icahn School of Medicine at Mount Sinai & James J Peters VA Medical Center, NY, NY

Nothing to Disclose: UF, TFD Disclosure Not Provided: NC
Petra Mohacsik, Dept. of Endocrine Neurobiology, Institute of Experimental Med, Budapest, Hungary, Ronald M Lechan, Dept of Med, Div of Endo, Tufts Medical Center, Boston, MA, Balazs Gereben, Endocrine Neurobiology, Hungarian Academy of Sciences, Hungary and Csaba Fekete, MD, PhD, Dept. of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary
Poster Board Number: SUN 239
Bu Beng Yeap, MBBS, FRACP, PhD1, Laurens Manning, MBChB, FRACP1, Paul Chubb, BSc, PhD2, Graeme J Hankey, MBBS, MD, FRACP1, Jonathan Golledge, MB BChir, MChir, FRACS3, Osvaldo P Almeida, MD, PhD, FRANZCP4 and Leon Flicker, MBBS, FRACP, PhD1, (1)School of Medicine and Pharmacology, University of Western Australia, Perth, Australia
(2)PathWest Laboratory Medicine, Fiona Stanley Hospital, Perth, Australia
(3)College of Medicine and Dentistry, James Cook University, Townsville, Australia
(4)School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, Australia
Poster Board Number: SUN 238
Marelle Yehuda, MD1, Chia-Hao Wang, PhD2, Ken C Chiu, MD3 and Andrew George Gianoukakis, MD1, (1)Division of Endocrinology and Metabolism, Harbor-UCLA Medical Center, Torrance, CA
(2)Department of Translational Research & Cellular Therapeutics, City of Hope National Medical Center, Duarte, CA
(3)Department of Clinical Diabetes, Endocrinology, and Metabolism, City of Hope National Medical Center, Duarte, CA
Poster Board Number: SUN 240
Tim IM Korevaar1, Daan Nieboer2, Peter H Bisschop, MD PhD3, Mariette Goddijn4, Marco Medici, MD5, Layal Chaker6, Yolanda B. de Rijke, PhD7, Vincent Jaddoe8, Henning Tiemeier9, Theo J Visser10, Ewout Steyerberg2, Tanja Vrijkotte4 and Robin P. Peeters11, (1)Dept. of endocrinology, Erasmus Medical Center, Rotterdam
(2)Public Health, Erasmus MC
(3)Department of Endocrinology and Metabolism, Academic Medical Center, Netherlands
(4)Amsterdam Medical Center
(5)Department of endocrinology, Erasmus medical center, Rotterdam, Netherlands
(6)Erasmus Medical Center, Rotterdam
(7)Clinical Chemistry, Erasmus MC, Rotterdam, Netherlands
(8)Erasmus MC
(9)Dept. of epidemiology, Erasmus Medical Center, Rotterdam
(10)Dept of Internal Med, Erasmus Univ Med Ctr, Rotterdam, Netherlands
(11)Internal Medecine, dept of Endoc, Erasmus Univ Rotterdam, Rotterdam, Netherlands
Poster Board Number: SUN 241

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire